NattoPharma ASA announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced total revenue was NOK 48.260 million compared to NOK 32.027 million a year ago. Operating income was NOK 1.748 million compared to NOK 1.277 million a year ago. Net loss was NOK 1.798 million compared to net income of NOK 2.903 million a year ago. Basic loss per share from continuing operations was NOK 0.11 compared to basic earnings per share from continuing operations of NOK 0.16 a year ago. For the nine months, total revenue was NOK 155.188 million compared to NOK 91.872 million a year ago. Operating income was NOK 11.725 million compared to operating loss of NOK 753,000 a year ago. Net income was NOK 31.259 million compared to NOK 1.458 million a year ago. Basic earnings per share from continuing operations was NOK 1.62 compared to NOK 0.08 a year ago. Diluted earnings per share from continuing operations was NOK 1.52 compared to NOK 0.08 a year ago.